NRx Pharmaceuticals announces initiation of Phase 2b trial of BriLife vaccine for Covid-19
Preclinical and early human data indicate BriLife may confer enhanced immunity against Delta variant
Preclinical and early human data indicate BriLife may confer enhanced immunity against Delta variant
India is dependent upon China and other countries for a lot of Key Starting Materials (KSM) for their bulk drug needs.
CDSCO to fast-track trials and approval for COVID19 vaccine
The data should be submitted by August 12th 2021
The govt has rolled out three schemes for promoting the manufacture of API
Celgene will grant Sun Pharma a license to Celgene’s patents required to manufacture and sell certain generic lenalidomide capsules
In an exclusive interview with Rahul Koul of Indian Chemical News, Priyanka Chigurupati, Executive Director, Granules Pharmaceuticals Inc. USA shared details about the company's performance, R&D initiatives, Capex plan, CSR, and future outlook. Excerpts of the interview:
7.94 crore doses were made available to the states in May 2021
Dr. Sharvil Patel cites the example of prescriptions being handed over to patients despite unavailability of enough stock of such medicines
Number of approved manufacturing sites of Remdesivir in the country has increased from 22 sites to 60
Subscribe To Our Newsletter & Stay Updated